Neurocrine Biosciences Presents New INGREZZA® (valbenazine) Data on Tardive Dyskinesia Improvement and Stability of Psychiatric Symptoms at American Psychiatric Association Annual Meeting 2022
/PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that it will present data on the use of INGREZZA® (valbenazine) capsules for the...
United States Eiryw Roberts Neurocrine Biosciences American Psychiatric Association Neurocrine Biosciences Inc Prnewswire Neurocrine Biosciences Inc
Source: prnewswire.com